Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REGAIN: A Randomized, Double Blind, Placebo Controlled Trial to Determine the Effects of Oxaloacetate on Improving Fatigue in Long COVID

NCT05840237 is registered in ClinicalTrials.gov with Terra Biological LLC as lead sponsor.

NCT NCT05840237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05840237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REGAIN: A Randomized, Double Blind, Placebo Controlled Trial to Determine the Effects of Oxaloacetate on Improving Fatigue in Long COVID
Lead sponsor
Terra Biological LLC
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2023
Completion date
January 30, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue syndrome, chronic, post-covid-19 syndrome